We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+8.47%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$314M
AUM Growth
+$42.8M
Cap. Flow
+$23.9M
Cap. Flow %
7.6%
Top 10 Hldgs %
24.48%
Holding
185
New
18
Increased
57
Reduced
47
Closed
10

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$6.19M
2
DAL icon
Delta Air Lines
DAL
+$5.64M
3
KR icon
Kroger
KR
+$5.41M
4
PAYC icon
Paycom
PAYC
+$5.15M
5
EW icon
Edwards Lifesciences
EW
+$5.07M

Top Sells

Rank Stock Value
1
FL
Foot Locker
FL
+$6.07M
2
AAP icon
Advance Auto Parts
AAP
+$5.83M
3
SNY icon
Sanofi
SNY
+$853K
4
XOM icon
ExxonMobil
XOM
+$483K
5
DOC icon
Healthpeak Properties
DOC
+$422K

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Industrials 14.4%
3 Technology 11.02%
4 Consumer Discretionary 10.46%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILMN icon
126
Illumina
ILMN
$28.4B
$346K 0.11%
1,850
UBSI icon
127
United Bankshares
UBSI
$6.62B
$337K 0.11%
9,110
EFA icon
128
iShares MSCI EAFE ETF
EFA
$80.2B
$336K 0.11%
5,714
APD icon
129
Air Products & Chemicals
APD
$67.6B
$332K 0.11%
2,759
KRE icon
130
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$327K 0.1%
7,800
-300
-4% -$13K
AVGO icon
131
Broadcom
AVGO
$2.04T
$316K 0.1%
21,750
DE icon
132
Deere & Co
DE
$168B
$309K 0.1%
4,055
TEVA icon
133
Teva Pharmaceuticals
TEVA
$41.2B
$302K 0.1%
4,603
FLR icon
134
Fluor
FLR
$7.96B
$292K 0.09%
6,180
ICLR icon
135
Icon
ICLR
$12.7B
$284K 0.09%
3,650
+200
+6% +$14.3K
UN
136
DELISTED
Unilever NV New York Registry Shares
UN
$282K 0.09%
6,500
PGEM
137
DELISTED
Ply Gem Holdings, Inc.
PGEM
$278K 0.09%
22,170
+7,170
+48% +$89.3K
TT icon
138
Trane Technologies
TT
$106B
$270K 0.09%
4,892
TCRT icon
139
Alaunos Therapeutics
TCRT
$4.86M
$269K 0.09%
216
+1
+0.5% +$1.65K
BUD icon
140
AB InBev
BUD
$165B
$263K 0.08%
2,105
+130
+7% +$15.7K
CELG
141
DELISTED
Celgene Corp
CELG
$247K 0.08%
2,062
WMT icon
142
Walmart Inc
WMT
$890B
$242K 0.08%
11,853
-150
-1% -$3.01K
ELV icon
143
Elevance Health
ELV
$85.5B
$239K 0.08%
1,716
+75
+5% +$10.3K
HDB icon
144
HDFC Bank
HDB
$121B
$239K 0.08%
15,500
+900
+6% +$13.6K
NXPI icon
145
NXP Semiconductors
NXPI
$60.4B
$238K 0.08%
2,820
EIRL icon
146
iShares MSCI Ireland ETF
EIRL
$78.5M
$237K 0.08%
5,700
VMC icon
147
Vulcan Materials
VMC
$36.9B
$228K 0.07%
2,400
NDSN icon
148
Nordson
NDSN
$17.3B
$226K 0.07%
3,528
F icon
149
Ford
F
$55.7B
$224K 0.07%
15,868
+1,850
+13% +$26.8K
MNP
150
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$224K 0.07%
14,350
+1,500
+12% +$23.1K

Similar funds

Dixon Hubard Feinour & Brown's Q4 2015 Portfolio in Review

As of Q4 2015, Dixon Hubard Feinour & Brown held 185 positions worth $314M, up 16% from $272M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dixon Hubard Feinour & Brown deployed $23.9M of net new capital in Q4 2015, opening 18 new positions and adding to 57 existing holdings. Its largest new stake was Constellation Brands: 44,930 shares worth $6.4M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Advance Auto Parts, an estimated $5.83M trimmed.

  • Dixon Hubard Feinour & Brown's largest Q4 2015 buy was Constellation Brands: 44,930 shares worth $6.4M.
  • Dixon Hubard Feinour & Brown added most to GE Aerospace in Q4 2015, an estimated $3.22M increase.
  • Dixon Hubard Feinour & Brown's biggest Q4 2015 reduction was Advance Auto Parts, cutting an estimated $5.83M.
  • Dixon Hubard Feinour & Brown fully exited Foot Locker in Q4 2015, selling an estimated $6.07M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $314M portfolio in Q4 2015.
  • Dixon Hubard Feinour & Brown opened 18 new positions and closed 10 in Q4 2015.
  • Dixon Hubard Feinour & Brown's portfolio value rose 16% quarter-over-quarter to $314M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2015, filed 12 Feb 2016.